[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB1099093A - Alkene derivatives - Google Patents

Alkene derivatives

Info

Publication number
GB1099093A
GB1099093A GB3770065A GB3770065A GB1099093A GB 1099093 A GB1099093 A GB 1099093A GB 3770065 A GB3770065 A GB 3770065A GB 3770065 A GB3770065 A GB 3770065A GB 1099093 A GB1099093 A GB 1099093A
Authority
GB
United Kingdom
Prior art keywords
cis
isomers
trans isomers
trans
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3770065A
Inventor
Dora Nellie Richardson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB3770065A priority Critical patent/GB1099093A/en
Publication of GB1099093A publication Critical patent/GB1099093A/en
Expired legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention comprises cis and trans isomers of compounds of the formula <FORM:1099093/C2/1> wherein R1 and R2 stand for alkyl radicals containing not more than 4 carbon atoms, or the -NR1R2 group stands for the morpholino radical, R3 and R4 stand for phenyl radicals, and X stands for a halogen atom, and the acid-addition salts thereof. The cis and trans isomers may be obtained by separation of the mixed isomers by known methods, for example, (1) by fractional crystallization of the mixed isomers or their acid-addition salts, from an organic solvent or mixture of solvents, or (2) by chromatography. An example, also describes the preparation of the mixed isomers of 1-(p-b -dimethylaminoethoxyphenyl) - 1,2 - diphenyl - 2-bromoethylene by reaction of 1-(p-hydroxyphenyl) -1,2-diphenyl-2-bromoethylene with b -dimethylaminoethyl chloride. Pharmaceutical and veterinary compositions comprise at least one of the cis and trans isomers of alkene derivatives of the above formula (other than a mixture of a cis isomer and its corresponding trans isomer) together with a pharmaceutically-acceptable diluent or carrier. The compositions are useful for the modification of the endocrine status in man and animals and may be used for the control of hormone-dependent tumours or for management of the sex-cycle and aberrations thereof. The trans isomers are preferred for anti-oestrogenic effects and the cis for oestrogenic effects. The compositions may be in the form of tablets, capsules, aqueous or oily solutions or suspensions, injectable aqueous or oily solutions or suspensions, dispersible powders or pre-mixes.
GB3770065A 1965-09-03 1965-09-03 Alkene derivatives Expired GB1099093A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB3770065A GB1099093A (en) 1965-09-03 1965-09-03 Alkene derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3770065A GB1099093A (en) 1965-09-03 1965-09-03 Alkene derivatives

Publications (1)

Publication Number Publication Date
GB1099093A true GB1099093A (en) 1968-01-17

Family

ID=10398386

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3770065A Expired GB1099093A (en) 1965-09-03 1965-09-03 Alkene derivatives

Country Status (1)

Country Link
GB (1) GB1099093A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0107208A1 (en) * 1982-10-26 1984-05-02 Klinge Pharma GmbH 1,1,2-Triphenyl-but-1-ene derivatives, process for their preparation and their use as medicines
US4536516A (en) * 1962-09-13 1985-08-20 Imperial Chemical Industries Plc Alkene derivatives
EP0287690A1 (en) * 1987-04-21 1988-10-26 HEUMANN PHARMA GMBH &amp; CO Stable solvent adducts of Z-1-(p-beta-dimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl)-2-phenylbut-1-ene
US4806685A (en) * 1985-08-05 1989-02-21 Gyogyszerkutato Inteezet/Pharmaceutical Research Institute 1,1,2-triphenylpropane and -propene derivatives
WO1995008528A1 (en) * 1993-09-24 1995-03-30 Merrell Pharmaceuticals Inc. Triaryl-ethylene derivatives for use in therapy
US5525633A (en) * 1993-09-24 1996-06-11 Merrell Dow Pharmaceuticals Inc. Triaryl-ethylene derivatives
US5691384A (en) * 1994-11-29 1997-11-25 Hoechst Marion Roussel, Inc. Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
US5693674A (en) * 1994-11-29 1997-12-02 Hoechst Marion Roussel, Inc. Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
US11046638B2 (en) 2019-11-14 2021-06-29 Apotex Inc. Processes for the preparation of zuclomiphene and intermediates thereof
US11440871B2 (en) 2019-11-14 2022-09-13 Apotex Inc. Zuclomiphene salts and crystalline forms thereof
US11661396B2 (en) 2020-01-22 2023-05-30 Apotex Inc. Crystalline forms of zuclomiphene citrate

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536516A (en) * 1962-09-13 1985-08-20 Imperial Chemical Industries Plc Alkene derivatives
EP0107208A1 (en) * 1982-10-26 1984-05-02 Klinge Pharma GmbH 1,1,2-Triphenyl-but-1-ene derivatives, process for their preparation and their use as medicines
US4806685A (en) * 1985-08-05 1989-02-21 Gyogyszerkutato Inteezet/Pharmaceutical Research Institute 1,1,2-triphenylpropane and -propene derivatives
EP0287690A1 (en) * 1987-04-21 1988-10-26 HEUMANN PHARMA GMBH &amp; CO Stable solvent adducts of Z-1-(p-beta-dimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl)-2-phenylbut-1-ene
US4973755A (en) * 1987-04-21 1990-11-27 Heumann Pharma Gmbh & Co. Stable solvent adducts of Z-1-(p-β-dimethylaminoethoxy-phenyl)-1-(p-hydroxyphenyl)-2-phenyl-but-1-ene
WO1995008528A1 (en) * 1993-09-24 1995-03-30 Merrell Pharmaceuticals Inc. Triaryl-ethylene derivatives for use in therapy
US5525633A (en) * 1993-09-24 1996-06-11 Merrell Dow Pharmaceuticals Inc. Triaryl-ethylene derivatives
US5691384A (en) * 1994-11-29 1997-11-25 Hoechst Marion Roussel, Inc. Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
US5693674A (en) * 1994-11-29 1997-12-02 Hoechst Marion Roussel, Inc. Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
US11046638B2 (en) 2019-11-14 2021-06-29 Apotex Inc. Processes for the preparation of zuclomiphene and intermediates thereof
US11440871B2 (en) 2019-11-14 2022-09-13 Apotex Inc. Zuclomiphene salts and crystalline forms thereof
US11661396B2 (en) 2020-01-22 2023-05-30 Apotex Inc. Crystalline forms of zuclomiphene citrate

Similar Documents

Publication Publication Date Title
GB1064629A (en) Alkene derivatives
GB1099093A (en) Alkene derivatives
Grob et al. The Derivation of Inductive Substituent Constants from pKa Values of 4‐Substituted Quinuclidines. Polar effects. Part I
NL177403B (en) PROCESS FOR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTIMICROBIC ACTION BASED ON A 14-DESOXY-14-ACETOXYMUTILINE DERIVATIVE AND METHOD FOR PREPARING A COMPOUND SUITABLE FOR THE SAID PROCESS.
ES412385A1 (en) Polyolefins stabilized with organic hydrazine compounds and phenolic antioxidants
GB1013907A (en) Alkene derivatives
GB881332A (en) Arylsulphonyl acrylonitriles and compositions containing the same
GB1344154A (en) Incorporating photographic additives into coating compositions
GB1077173A (en) Substituted alkylene piperidines and methods of preparation thereof
ES391633A1 (en) 2,2,-diaryl-4-4-aryl-4-hydroxy-piperidino butyramides
ES324864A1 (en) Procedure for the preparation of antiparasitary agents. (Machine-translation by Google Translate, not legally binding)
GB1029221A (en) Triarylalkane derivatives
ES295832A1 (en) Procedure for the preparation of antiparasitaries (Machine-translation by Google Translate, not legally binding)
GB978288A (en) New nicotinic acid phenyl-ethylamides and preparations containing them
GB1067244A (en) Benzonaphthindolizine-dione-carboxyarylamide pigments
US3115502A (en) Method of isomerizing basically substituted stereoisomeric thioxanthenes
GB1109848A (en) New dibenzocycloheptadiene derivatives and process for their preparation
GB917944A (en) í~-androstenes and method of preparing the same
ES332645A1 (en) Procedure for the preparation of new N-heterocicles. (Machine-translation by Google Translate, not legally binding)
ES316528A1 (en) Procedure for preparing agents to combat parasites. (Machine-translation by Google Translate, not legally binding)
GB1002005A (en) New benzanilide derivatives
GB1032253A (en) Coumarin derivatives and process for the production thereof
GB984028A (en) Estradiol derivatives and methods for their production
GB1046001A (en) Propanolamine derivatives
GB1059839A (en) Process for preparing ketones and novel ketones so prepared